Patents by Inventor Morris Mann

Morris Mann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7261907
    Abstract: A non-stoichiometric clathrate of lipid and sulfur has been shown to effectively stabilize nerve cell membranes. As such, said compound has proven useful in a variety of neuropsychiatric disorders such as, addiction, depression, autism, Tourette's syndrome, and the like.
    Type: Grant
    Filed: August 30, 2005
    Date of Patent: August 28, 2007
    Inventor: Morris Mann
  • Publication number: 20050287229
    Abstract: A non-stoichiometric clathrate of lipid and sulfur has been shown to effectively stabilize nerve cell membranes. As such, said compound has proven useful in a variety of neuropsychiatric disorders such as, addiction, depression, autism, Tourette's syndrome, and the like.
    Type: Application
    Filed: August 30, 2005
    Publication date: December 29, 2005
    Inventor: Morris Mann
  • Publication number: 20040005368
    Abstract: Formulations and methods for enhancing lipolysis and the suppression of appetite are presented. Currently the preferred embodiment has these formulations as two separate compositions because of taste considerations (the combined taste, currently, is disagreeable). However, it is known that the two separate compositions can be combined into a single delivery systems, such as a drink, bar, gel or other nutritional delivery system known in the arts. The two separate compositions are: 1. compositions comprising substances that enhance oxygen uptake, and 2. a protein supplement composition comprising substances that regulate blood sugar. The overall purpose of this invention is to induce weight loss in as short of time as possible with the least amount of discomfort.
    Type: Application
    Filed: July 1, 2002
    Publication date: January 8, 2004
    Inventors: Morris Mann, Maria A. Mann
  • Publication number: 20030207932
    Abstract: The ingestion or topical administration of substances that inhibit leukotrienes prior to a trauma to the skin and for a period of time thereafter effectively inhibits the development of hyperpigmentation in people so predisposed.
    Type: Application
    Filed: May 1, 2003
    Publication date: November 6, 2003
    Inventor: Morris Mann
  • Patent number: 6624312
    Abstract: A method for purifying various nitrogen containing flavor and fragrance compounds is described. The method comprises at least one step of reverse crystallization for liquid compounds and may be followed by at least one step of forward crystallization for compounds that are solid at room temperature.
    Type: Grant
    Filed: February 26, 2001
    Date of Patent: September 23, 2003
    Inventor: Morris Mann
  • Patent number: 6558656
    Abstract: Described are compositions and methods for the treatment of acne. The method and compositions comprise an orally ingested composition containing thymic peptides, vitamins, and minerals. Zinc, pantothenic acid, magnesium, pyridoxine, vitamins A and D, riboflavin, and folic acid are found to be essential to the composition. Also described is a topical composition comprising pantothenic acid that, when used in conjunction with the oral composition, resulted in a better response than either the oral or topical composition alone.
    Type: Grant
    Filed: March 26, 2002
    Date of Patent: May 6, 2003
    Inventor: Morris Mann
  • Publication number: 20030036514
    Abstract: The present invention is directed to a group of linear and cyclic peptides having the structures:
    Type: Application
    Filed: July 18, 2002
    Publication date: February 20, 2003
    Inventors: Morris Mann, Maria A. Mann
  • Publication number: 20020187233
    Abstract: Described are methods and compositions that eliminate the aftertaste of the various non-nutritive sweeteners. These include, but are not limited to, sucralose, aspartame and acesulfame-k (also known as the potassium salt of ascesulfame). In addition, methods and compositions are described which allow for stability of various flavoring compositions used in conjunction with non-nutritive sweeteners.
    Type: Application
    Filed: June 5, 2002
    Publication date: December 12, 2002
    Inventors: Morris Mann, Cheryl R. Mitchell
  • Publication number: 20020164382
    Abstract: A non-stoichiometric clathrate of lipid and sulfur has been shown to effectively stabilize nerve cell membranes. As such, said compound has proven useful in a variety of neuropsychiatric disorders such as, addiction, depression, autism, Tourette's syndrome, and the like.
    Type: Application
    Filed: April 19, 2002
    Publication date: November 7, 2002
    Inventor: Morris Mann
  • Publication number: 20020155083
    Abstract: The present invention generally relates to compositions and methods for dermal regeneration, both alone and in conjunction with LASER phototherapy. The method comprises the steps of applying an abrasive scrub to a selected area of a dermis to be treated to remove keratin from an epidermis; applying a keratin solvent system to the selected area of the dermis to be treated after the step of applying an abrasive scrub to further remove keratin from the epidermis; applying an acid chemical peel composition to the area of the dermis to be treated; and applying a thymic peptide based composition on the area of the dermis. A LASER phototherapy treatment may be substituted or used in conjunction with the acid chemical peel treatment. Additionally, microdermabrasion or epidermabrasion may be used prior to the chemical peel.
    Type: Application
    Filed: March 26, 2002
    Publication date: October 24, 2002
    Inventor: Morris Mann
  • Publication number: 20020155171
    Abstract: Described are compositions and methods for the treatment of acne. The method and compositions comprise an orally ingested composition containing thymic peptides, vitamins, and minerals. Zinc, pantothenic acid, magnesium, pyridoxine, vitamins A and D, riboflavin, and folic acid are found to be essential to the composition. Also described is a topical composition comprising pantothenic acid that, when used in conjunction with the oral composition, resulted in a better response than either the oral or topical composition alone.
    Type: Application
    Filed: March 26, 2002
    Publication date: October 24, 2002
    Inventor: Morris Mann
  • Publication number: 20020127179
    Abstract: A method for purifying various nitrogen containing flavor and fragrance compounds is described. The method comprises at least one step of reverse crystallization for liquid compounds and may be followed by at least one step of forward crystallization for compounds that are solid at room temperature.
    Type: Application
    Filed: February 26, 2001
    Publication date: September 12, 2002
    Inventor: Morris Mann
  • Publication number: 20010043957
    Abstract: A composition for increasing lipolysis by enhancing oxygen transport is described. The composition comprises a thermogenic/lipolytic composition comprising a neurotransmitter replacement composition; an anti-inflammatory agent composition; an appetite suppressant composition; and a mineral replacement composition; wherein said thermogenic/lipolytic composition comprises at least one of the components selected from the group consisting of an Ephedra containing herb, a Theophylline extract, a Caffeine extract, and a Coleus Forskhollii extract; said neurotransmitter replacement composition comprises at least one of the components selected from the group consisting of an L-Tyrosine extract, Dimethylaminoethanol, Choline Citrate, and Huperzine-A; said anti-inflammatory agent composition comprises White Willow Bark; said appetite suppressant composition comprises at least one of the components selected from the group consisting of St.
    Type: Application
    Filed: February 12, 2001
    Publication date: November 22, 2001
    Inventor: Morris Mann